Temporal cytokine profiling of Francisella tularensis-infected human peripheral blood mononuclear cells

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 3, 2008, Pages 192-199

  Paranavitana, Chrysanthi ^a   Pittman, Phillip ^b   Velauthapillai, Mahendran ^c   DaSilva, Luis ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cytokines; Francisella tularensis; Immunity, cellular; Macrophages; Tularemia

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNINDEXED DRUG; VASCULOTROPIN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BACTERIUM DETECTION; CELL POPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; FRANCISELLA TULARENSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION; INTRACELLULAR BACTERIUM; MACROPHAGE; MALE; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SECRETION; SUPERNATANT; TULAREMIA; BACTERIAL COUNT; BIOSYNTHESIS; BLOOD; CYTOPLASM; IMMUNOLOGY; MICROBIOLOGY; MONONUCLEAR CELL; TIME;

ADULT; BLOOD; COLONY COUNT, MICROBIAL; CYTOKINES; CYTOPLASM; FRANCISELLA TULARENSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; MALE; TIME FACTORS;

EID: 53749108512     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002;15:631-46.
2. Santic M, Molmeret M, Abu Kwaik Y. Modulation of biogenesis of the Francisella tularensis subsp. novicida-containing phagosome in quiescent human macrophages and its maturation into a phagolysosome upon activation by IFN-gamma. Cell Microbiol. 2005;7:957-67.
3. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev. 2000;173:39-51.
4. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8:275-83.
5. Jansky L, Reymanová P, Kopecky J. Dynamics of cytokine production in human peripheral blood mononuclear cells stimulated by LPS or infected by Borrelia. Physiol Res. 2003;52:593-8.
6. Babu S, Nutman TB. Proinflammatory cytokines dominate the early immune response to filarial parasites. J Immunol. 2003;171:6723-32.
7. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383:787-93.
8. Rogers KA, Titus RG. The human cytokine response to Leishmania major early after exposure to the parasite in vitro. J Parasitol. 2004;90:557-63.
9. Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines. J Leukoc Biol. 2005;77:893-7.
10. Telepnev M, Golovliov I, Sjöstedt A. Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog. 2005;38:239-47.
11. Butchar JP, Rajaram MV, Ganesan LP Parsa KV, Clay CD, Schlesinger LS, et al. Francisella tularensis induces IL-23 production in human monocytes. J Immunol. 2007;178:4445-54.
12. Gavrilin MA, Bouakl IJ, Knatz NL, Duncan MD, Hall MW, Gunn JS, et al. Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release. Proc Natl Acad Sci USA. 2006;103:141-6.
13. Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, et al. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med. 2001;194:519-27.
14. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest. 1990;86:972-80.
15. Patarca R, Fletcher MA. Interleukin-1: basic science and clinical applications. Crit Rev Oncog. 1997;8:143-88.
16. Acres RB, Larsen A, Conlon PJ. IL 1 expression in a clone of human T cells. J Immunol. 1987;138:2132-6.
17. Clinchy B, Gunnerås M, Håkansson A, Håkansson L. Production of IL-1Ra by human mononuclear blood cells in vitro: influence of serum factors. Cytokine. 2006;34: 320-30.
18. Dabrowski MP, Stankiewicz W, P?usa T, Chcia?owski A, Szmigielski S. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA. Mediators Inflamm. 2001;10:101-7.
19. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem. 1991;266:10331-6.
20. Granowitz EV, Clarck BD, Mancilla J, Dinarello CA. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem. 1991;266:14147-50.
21. Fortier AH, Green SJ, Polsinelli T, Jones TR, Crawford RM, Leiby DA, et al. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol Ser. 1994;60:349-61.
22. Cowley SC, Elkins KL. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med. 2003;198:379-89.
23. Cowley SC, Hamilton E, Frelinger JA, Su J, Forman J, Elkins KL. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo. J Exp Med. 2005;202:309-19.
24. Karttunen R, Surcel HM, Andersson G, Ekre HP, Herva E. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings. J Clin Microbiol. 1991;29:753-6.
25. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1-8.
26. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol. 2006;6:329-33.
27. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol. 2000;165:6107-15.
28. Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res. 2006;34:229-42.
29. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6:1133-41.
30. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123-32.
31. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol. 2005;175:788-95.
32. Wu Q, Martin RJ, Rino JG, Breed R, Torres RM, Chu HW. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes Infect. 2007;9:78-86.
33. Ziolkowska M, Koc A, Luszczykiewicz G, Ksiezopolska-Pietrzak K, Klimczak E, Chwalinska-Sadowska H, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol. 2000;164:2832-8.
34. Nishigaki Y, Fujiuchi S, Fujita Y, Yamazaki Y, Sato M, Yamamoto Y, et al. Increased serum level of vascular endothelial growth factor in Mycobacterium avium complex infection. Respirology. 2006;11:407-13.
35. Schulte B, Linke D, Klumpp S, Schaller M, Riess T, Autenrieth IB, et al. Bartonella quintana variably expressed outer membrane proteins mediate vascular endothelial growth factor secretion but not host cell adherence. Infect Immun. 2006;74:5003-13.
36. Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors. Am J Pathol. 2003;163:711-21.